Skip to content
value.today

Weleda

Unlisted company
No market cap data
Compare
World rank
—
no current market cap
Revenue
$478 M
Fiscal year 2020
Wikidata
Net income
—
Employees
2,512
As of 2020
Wikidata

Weleda in brief

Weleda is an unlisted company in the Healthcare sector, based in Arlesheim, Switzerland. It was founded in 1921. In its latest reported year it had sales of $478 M. It employs about 2,512 people and Nataliya Yarmolenko is its chief executive.

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About Weleda

Weleda is a multinational company that produces both beauty products and naturopathic medicines. Both branches design their products based on anthroposophic principles, an alternative medicine.

The company takes its name from the German form of the name of the 1st-century Bructeri völva Veleda. As well as being known to use green energy, Weleda uses natural ingredients grown using biodynamic methods and none of their ingredients or products are tested on animals.

Weleda Group is member of the Union for Ethical Biotrade (UEBT).

From Wikipedia: read the full article · text available under CC BY-SA 4.0

Weleda timeline

7 events, 1921–2020
  1. 1921
  2. 🏁
    · approximate
    Founded by Rudolf Steiner and Ita Wegman
  3. 2012
  4. 👤
    Andreas Sommer became CEO
    CEO until September 2019.
  5. 2014
  6. 👤
    Michael Brenner became CEO
  7. 2016
  8. 👤
    Aldo Ammendola became CEO
  9. 2018
  10. 💰
    Record revenue of $486 million
    FY2018, the highest of the 9 years on record.
  11. 👤
    Alois Mayer became CEO
  12. 2020
  13. 👤
    Nataliya Yarmolenko became CEO

Events of Weleda from Wikidata and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

Not enough history yet.

Financial history

USD · fiscal years
RevenueNet income
Fiscal year ending 2013: revenue $447M, net income —$447M2013Fiscal year ending 2014: revenue $483M, net income —$483M2014Fiscal year ending 2015: revenue $432M, net income —$432M2015Fiscal year ending 2016: revenue $431M, net income —$431M2016Fiscal year ending 2017: revenue $452M, net income —$452M2017Fiscal year ending 2018: revenue $486M, net income —$486M2018Fiscal year ending 2019: revenue $480M, net income —$480M2019Fiscal year ending 2020: revenue $484M, net income —$484M2020
Fiscal year endingRevenueGrowthOperating incomeNet incomeNet margin
2020$484M+0.7%———
2019$480M-1.2%———
2018$486M+7.6%———
2017$452M+4.8%———
2016$431M-0.1%———
2015$432M-10.6%———
2014$483M+8.1%———
2013$447M————

Annual results

Revenue
$478 M
Operating income
—
Net income
—

Fiscal year 2020 · source: Wikidata (cited)

Weleda scorecard#

Passes 1 of the 4 checks that could be worked out. Fiscal year 2020.

  • Valuationnot known
    • –P/E below its peers' medianNo market cap.
    • –Price to book below its peers' medianNo market cap.
    • –Price to sales below its peers' medianNo market cap.
    • –Free cash flow yield above 5%No market cap.
    • –Earnings yield above the 10-year Treasury yieldNo market cap.
    • –The price assumes slower growth than the last three years'No market cap.
  • Growth1 of 4
    • ✓Revenue grew in the newest year0.7%Revenue up 0.7% in fiscal 2020.
    • ✗Revenue up more than 5% a year over three years2.3%2.3% a year over the three years to fiscal 2020.
    • ✗Faster growth over three years than its peers' median2.3%2.3% a year against Healthcare's median of 8.5% (549 companies).
    • –Earnings per share grew in the newest yearEarnings per share of two years are not on file.
    • –Net income higher than five years earlierNet income of five years earlier is not on file.
    • ✗Revenue rose in at least four of the last five years3 of 5Revenue rose in 3 of the five years to fiscal 2020.
  • Profitabilitynot known
    • –Profitable in the newest yearNo net income on file.
    • –Profitable in each of the last five yearsFive years of net income are not on file.
    • –Operating margin above its peers' medianNo operating margin on file.
    • –Return on equity above 15%No return on equity (equity missing or negative).
    • –Return on invested capital above 10%No return on invested capital on file.
    • –Operating margin wider than three years earlierOperating margins of three years earlier are not on file.
  • Financial healthnot known
    • –Short-term assets cover short-term liabilitiesCurrent assets and liabilities are not on file.
    • –Debt below equityDebt or equity is not on file (or equity is negative).
    • –Net debt below three years of EBITDANet debt to EBITDA is not on file.
    • –Operating income covers interest five timesInterest expense is not on file.
    • –Cash from operations positive in each of the last three yearsThree years of operating cash flow are not on file.
    • –Altman Z-score outside the distress zoneThe Z-score's figures are not all on file.
  • Shareholder returnsnot known
    • –Pays a dividendDividends are not on file.
    • –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
    • –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
    • –Share count up no more than 2% in a yearShare counts of two years are not on file.
    • –Dividends and buybacks above 3% of the market valueNo market cap.
    • –Free cash flow covers dividends and buybacksCash from operations or capital spending is not on file.

Worked out from the statements as filed (wikidata), the medians of Healthcare, the 10-year Treasury yield of Nov 13, 2026 and the market cap (too old for the valuation checks, which need one at most 60 days old). A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work

How Weleda compares in Healthcare

  • Revenue$478 M · higher than 64% of 1,795
  • Revenue growth0.7% · higher than 35% of 1,003
CompanyMarket capP/ENet marginRev. growth
Weleda🇨🇭———+0.7%
Eli Lilly and Company🇺🇸$1.20 T43.4×31.9%+44.7%
Johnson & Johnson🇺🇸$652.5 B40.5×16.2%+6.0%
AbbVie Inc.🇺🇸$514.0 B49.7×15.7%+8.6%
Roche Holding AG🇨🇭$370.3 B29.1×19.0%—
UnitedHealth Group Incorporated🇺🇸$367.7 B23.1×3.5%+11.8%
Merck & Co., Inc.🇺🇸$359.8 B146.7×3.6%+1.3%
Novartis AG🇨🇭$286.8 B20.5×24.7%—
Thermo Fisher Scientific Inc.🇺🇸$253.8 B35.9×14.9%+3.9%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Annual results:
Fiscal year 2020
Employees:
As of 2020
Profile updated:
Nov 5, 2026

Figures from Wikidata, Wikipedia, value.today research.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Weleda? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Weleda's ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Weleda? Suggest a correction